Many peptide-focused clinics don't offer it, while others question its long-term safety profile
The Korean biotech company, which focuses on the development of glucagon-like peptide-1 receptor (GLP-1R) agonistsdrugs that mimic glucose-regulating hormonessaid on Tuesday that the FDA approved its investigational new drug (IND) application for this trial
Key actives include PDRN skin boosters, Glutathione for skin, barrier lipids, and stabilised antioxidants
However, monitoring nutrient intake, especially for fat-soluble vitamins, is important
11,239 It is also possible that GLP-1 therapies mediate beneficial actions via extra cardiovascular GLP-1 signalling, as one study reported that exendin-4 administration in rat femoral arteries did not affect short-term triglyceride exposure-induced endothelial dysfunction
Their team will give you straight answers rather than vague reassurances